The fact that both insulin and glucagon concentrations were reduced suggests that the fetal hypoglycemia induced by SLC2A3 RNAi during the first half of gestation had an overall effect on pancreas development and growth, rather than a β cell-specific effect. The gene discussed is GCG; the disease is Hypoglycemia.